Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EpigenOMic Determinants of the Neuroendocrine Phenotype As Biomarkers for Noninvasive Diagnosis of Neuroendocrine Neoplasms

NCT06785597 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT06785597
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06785597 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EpigenOMic Determinants of the Neuroendocrine Phenotype As Biomarkers for Noninvasive Diagnosis of Neuroendocrine Neoplasms
Lead sponsor
European Institute of Oncology
Phase
Observational
Overall status
Recruiting
Start date
October 21, 2024
Completion date
October 21, 2026
Enrollment
130 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mixed neuroendocrine-non neuroendocrine neoplasm, neuroendocrine neoplasm